| Ms Diane Brousseau-pizzi, PCNS | |
|
125 Revere Ave, West Warwick, RI 02893-3938 | |
| (401) 965-1947 | |
| Not Available |
| Full Name | Ms Diane Brousseau-pizzi |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist |
| Location | 125 Revere Ave, West Warwick, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689667370 | NPI | - | NPPES |
| 408600 | Other | RI | BLUE CHIP OF RI |
| 1021340 | Other | RI | NEIGHBORHOOD HLTH PLAN RI |
| 463957 | Other | TUFTS HLTH PLAN | |
| 223229 | Other | RI | BCBS OF RI |
| 6265640 | Other | UNITED HLTH OF NE | |
| DB35712 | Other | RI | MEDICAID RITE SHARE OF RI |
| 349426 | Other | MA | BCBS OF MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN23411 (Rhode Island) | Secondary |
| 364S00000X | Clinical Nurse Specialist | PNS00015 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Diane Brousseau-pizzi, PCNS 125 Revere Ave, West Warwick, RI 02893-3938 Ph: (401) 965-1947 | Ms Diane Brousseau-pizzi, PCNS 125 Revere Ave, West Warwick, RI 02893-3938 Ph: (401) 965-1947 |
News Archive
Alzheimer's disease, the leading cause of dementia, has long been assumed to originate in the brain. But research from the University of British Columbia and Chinese scientists indicates that it could be triggered by breakdowns elsewhere in the body.
Howard Hughes Medical Institute scientists at The Salk Institute have discovered a new class of optical illusion that they have studied in detail to show that humans use both the timing and spatial context of a visual stimulus to judge brightness.
Following the news that the Drug Controller General of India has given license to Roche Diagnostics India to conduct coronavirus tests, Rohit Anand, Medical Devices Analyst at GlobalData, a leading data and analytics company, offers his view.
OrbusNeich announced today that interim data from a prospective registry showed good safety in a broad population of patients that underwent primary percutaneous coronary intervention (PCI) and implantation of the company's Genous Bio-engineered R stent for ST-elevation myocardial infarction (STEMI).
Dana-Farber Cancer Institute scientists report they have shrunk or slowed the growth of notoriously resistant pancreatic tumors in mice, using a drug routinely prescribed for malaria and rheumatoid arthritis.
› Verified 1 days ago